Sufentanil

In the US, Sufentanil (sufentanil systemic) is a member of the drug class narcotic analgesics and is used to treat Anesthesia.

US matches:

• Sufentanil
• Sufentanil Injection
• Sufentanil Citrate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N01AH03

CAS registry number (Chemical Abstracts Service)

0056030-54-7

Chemical Formula

C22-H30-N2-O2-S

Molecular Weight

386

Therapeutic Categories

Opioid analgesic

Anesthetic, injectable

Chemical Name

Propanamide, N-[4-(metoxymetyl)-1-[2-(2-tienyl)etyl]-4-piperidinyl]-N-phenyl-

Foreign Names

• Sufentanilum (Latin)
• Sufentanil (German)
• Sufentanil (French)
• Sufentanilo (Spanish)

Generic Names

• Sufentanil (OS: BAN, USAN, DCF, DCIT)
• R 30730 (IS: Janssen)
• Sufentanil (PH: BP 2016, Ph. Eur. 8)
• Sufentanilum (PH: Ph. Eur. 8)
• Sufentanil Citrate (OS: BANM, USAN)
• R 33800 (IS)
• Sufentanil (citrate de) (PH: Ph. Eur. 8)
• Sufentanil Citrate (PH: BP 2016, Ph. Eur. 8, USP 38)
• Sufentanil citrate (PH: Ph. Eur. 8)
• Sufentanilcitrat (PH: Ph. Eur. 8)
• Sufentanili citras (PH: Ph. Eur. 8)

Brand Names

• Sufenta
  Janssen-Cilag, Tunisia; Johnson & Johnson, Indonesia
• Sufentamed
  Unimed, Tunisia
• Sufentanil Chiesi
  Chiesi, Slovakia
• Sufentanil Forte Labatec
  Labatec Pharma, Switzerland
• Sufentanil Hameln
  Sanolabor, Slovenia
• Sufentanil Labatec
  Labatec Pharma, Switzerland
• Sufentanil Renaudin
  LENIS, Slovenia
• Sufentanilo G.E.S
  Ges Genericos, Spain
• Zalviso
  Grünenthal, France
• Disufen
  Angenerico, Italy
• Fastfen
  Cristalia, Brazil
• Fentatienil
  Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F S., Italy
• Pharma-Q Sufentanil
  Pharma-Q, South Africa
• Sufenta
  Akorn, United States; GlaxoSmithKline, Netherlands; Janseen Pharmaceutica, Oman; Janssen, Brazil; Janssen, Chile; Janssen, Finland; Janssen, Iceland; Janssen, Norway; Janssen, South Africa; Janssen Cilag, Argentina; Janssen-Cilag, Belgium; Janssen-Cilag, Switzerland; Janssen-Cilag, Czech Republic; Janssen-Cilag, Germany; Janssen-Cilag, Denmark; Janssen-Cilag, France; Janssen-Cilag, Portugal; Janssen-Cilag Pharma, Austria; Johnson & Johnson, Slovakia
• Sufenta Forte
  Janseen Pharmaceutica, Oman; Janssen, Belgium; Janssen, Finland; Janssen Cilag, Serbia; Janssen-Cilag, Czech Republic
• Sufenta forte
  GlaxoSmithKline, Netherlands; Janssen Cilag, Netherlands; Janssen-Cilag, Switzerland
• Sufenta mite
  Janssen-Cilag, Germany
• Sufenta-epidural
  Janssen-Cilag, Germany
• Sufentanil Actavis
  Actavis Group, Austria
• Sufentanil Chiesi
  Chiesi Pharmaceuticals, Poland
• Sufentanil Citrate Sandoz
  Sandoz, Canada
• Sufentanil Eurocept
  Eurocept, France
• Sufentanil Hameln
  Hameln, Portugal; Hospira Italia, Italy; Matrix Pharmaceuticals, Denmark
• Sufentanil HEXAL
  Hexal, Germany
• Sufentanil Mylan
  Mylan, France; Mylan, Belgium
• Sufentanil Narcomed
  EuroCept, Netherlands
• Sufentanil Renaudin
  Renaudin, France
• Sufentanil Torrex
  Chiesi, Hungary; Torrex, Czech Republic; Torrex-Chiesi, Romania
• Sufentanil-Actavis
  Actavis, Germany
• Sufentanil-hameln
  Hameln Pharmaceuticals, Austria; Hameln, Netherlands; Hameln Pharma Plus, Germany
• Sufentanilo Hikma
  Hikma, Portugal
• Zalviso
  Grunenthal, United Kingdom
• Zuftil
  Pisa, Mexico

Glossary

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer